Compounds > 3-hydroxybenzylhydrazine
Page last updated: 2024-10-21

3-hydroxybenzylhydrazine and Atherosclerotic Parkinsonism

3-hydroxybenzylhydrazine has been researched along with Atherosclerotic Parkinsonism in 2 studies

3-hydroxybenzylhydrazine: decarboxylase inhibitor; RN given refers to parent cpd; structure

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Richard, MG1
Bennett, JP1
Sundström, E1
Fredriksson, A1
Archer, T1

Other Studies

2 other studies available for 3-hydroxybenzylhydrazine and Atherosclerotic Parkinsonism

ArticleYear
Regulation by D2 dopamine receptors of in vivo dopamine synthesis in striata of rats and mice with experimental parkinsonism.
    Experimental neurology, 1994, Volume: 129, Issue:1

    Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Corpus Striatum; Dihydroxyphenylalanine; Dopa

1994
Chronic neurochemical and behavioral changes in MPTP-lesioned C57BL/6 mice: a model for Parkinson's disease.
    Brain research, 1990, Oct-01, Volume: 528, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apomorphine; Body Weight; Corpus Striatum; Di

1990